ArticleThe British journal of radiology2026
Feasibility of 3D photoacoustic tomography for the assessment of rheumatoid arthritis.
Article in The British journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesTo assess whether 3D photoacoustic tomography (PAT) using the Fabry-Perot (FP) scanner can (1) reliably detect synovitis in participants with rheumatoid arthritis (RA), and (2) assess the severity of active inflammation.
methodsA total of 247 3D-PAT images of the finger and wrist joint from 11 healthy volunteers and 9 patients with RA were obtained using the FP scanner. Patients underwent power doppler ultrasound (PDUS) assessment of RA disease activity. The 3D-PAT images were acquired over a 15 × 15 × 10 mm3 volume in <15 s. The images were assessed quantitatively by segmentation of the vasculature using k-means clustering followed by skeletonization to measure vascular path length (PAT-VPL). Patient and volunteer PAT-VPL were compared using t-tests and area under the receiver operating characteristic curve (ROC-AUC).
resultsThe 3D-PAT differentiates between unaffected and affected joints in patients with RA, showing a statistically significant difference in PAT-VPL (unaffected joint: 11.88 mm, affected joints: 45.7 mm, P < .001). The ROC-AUC was 0.91 (95% confidence interval [CI]: 0.81-0.96), with sensitivity and specificity of 86% (95% CI: 72%-95%) and 78% (95% CI: 60%-90%), respectively. PAT-VPL was associated with PDUS-based clinical severity grade, with a correlation coefficient of 0.74 (95% CI: 0.67-0.8). Significant differences in PAT-VPL were observed between each clinical severity group.
conclusionsThe FP scanner generates rapid high-resolution quantitative 3D-PAT images of the synovial microvasculature that can be used to distinguish between inflamed and non-inflamed joints, and assess the severity of active inflammation. ADVANCES IN KNOWLEDGE: The 3D-PAT FP scanner reliably distinguishes between affected and unaffected finger and wrist joints in patients with rheumatoid arthritis. Compared to previous 2D PAT scanners used to image joint inflammation, it offers superior image quality and the prospect of mitigating operator-dependent variations in probe positioning by virtue of its 3D imaging capability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.